CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Unichem Pharmaceuticals USA Inc. recalls Doxazosin Tablets

Read the official FDA notice

Published
18 Feb 2026
Units affected
60,000 tablets
Agency
FDA
Country
United States

The hazard

Tablets/Capsules Imprinted with Wrong ID

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.

Brand / company
Unichem Pharmaceuticals USA Inc.
Codes / lots
Lot # GDSH25006, Exp Date: 08/2027
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 18 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.